Putnam, an Inizio Advisory Company, is a premier strategic consulting partner for pharmaceutical and life science companies serving a range of biopharmaceutical, diagnostics, medtech, and private equity/venture capital clients. For more than 30 years, we have provided high-impact strategic advice and analytical services, helping our clients solve their most complex challenges across the patient journey and franchise lifecycle to bring preventions and treatments to those that need them. We offer an unparalleled depth and breadth of advisory service expertise combined with scientific and technical capabilities across strategic and therapeutic areas. We listen to client needs, help shape hypotheses, analyze data, and advise on the strategy of life-changing therapies, empowering better decisions to create long-term value for patients. 

Our Putnam PHMR team is part of our Value, Pricing and Access (VPA) practice area function, where our team members bring a breadth of knowledge across scientific and technical capabilities. We are a team of highly qualified HTA experts, health economists, and research scientists, helping clients to demonstrate and communicate value essential for pricing and market access success.

We are proudly part of Inizio Advisory, a trusted advisor for pharmaceutical and life science companies offering sector specific connected solutions.

Putnam PHMR

Mark Ratcliffe

Dorota Mrozek

Żaneta Tomaszewska

The Market Access and Health Economics team at Putnam PHMR specializes in guiding pharmaceutical and life science companies through the complexities of pricing, reimbursement, and market access strategies. Leveraging expertise in health economics, outcomes research, and health technology assessments (HTAs), the team conducts comprehensive analyses to demonstrate the value of innovative therapies, ensuring clients effectively communicate their benefits to payers and stakeholders. Through meticulous data analysis and strategic insights, they empower clients to navigate the healthcare landscape, optimize pricing models, and enhance patient access to life-changing treatments.

Market Access and Health Economics

The Leadership Team at Putnam PHMR is responsible for setting strategic direction and ensuring operational excellence within the Value, Pricing, and Access practice area. They leverage their extensive expertise in health economics, market access, and HTA to guide the organization's initiatives, foster innovation, and drive client success. By aligning team goals with client needs and industry trends, the Leadership Team plays a critical role in delivering high-impact advisory services that optimize market strategies for biopharmaceutical and life science companies.

Leadership Team

The Market Access and Analytics Team at Putnam PHMR specializes in bridging the gap between scientific research and market strategy for pharmaceutical and life science clients. This team leverages expertise in health economics, real-world evidence (RWE) analytics, and pricing strategy to demonstrate the value of therapies, ensuring successful market access and optimal pricing. By analyzing data and developing robust models, they empower clients to make informed decisions that enhance patient access to life-changing treatments.

Putnam PHMR

Org chart

Teams

Market Access and Health Economics

Leadership Team

Market Access and Analytics Team

Offices

Putnam PHMR

Org chart

Teams

Market Access and Health Economics

Leadership Team

Market Access and Analytics Team

Offices

Related companies